Home
BCYC
BCYC News

Latest Bicycle Therapeutics plc (BCYC) News on August 23, 2025

MT Newswires

2 months ago

European Equities Traded in the US as American Depositary Receipts Rise in Friday Trading; Up 2.5% for Week

MT Newswires

2 months ago

European Equities Traded in the US as American Depositary Receipts Edge Higher Wednesday

Is Bicycle Therapeutics (NASDAQ:BCYC) In A Good Position To Invest In Growth?

Simply Wall St.

2 months ago

Is Bicycle Therapeutics (NASDAQ:BCYC) In A Good Position To Invest In Growth?

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

3 months ago

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Bicycle Therapeutics Announces Poster Presentations at the 2025 ASCO Annual Meeting

Business Wire

3 months ago

Bicycle Therapeutics Announces Poster Presentations at the 2025 ASCO Annual Meeting

GuruFocus.com

3 months ago

Eckert & Ziegler SE (XTER:EUZ) Q1 2025 Earnings Call Highlights: Strategic Partnerships and ...

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

4 months ago

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Is Bicycle Therapeutics plc (BCYC) the Best Small Cap Stock to Buy with the Biggest Upside Potential?

Insider Monkey

4 months ago

Is Bicycle Therapeutics plc (BCYC) the Best Small Cap Stock to Buy with the Biggest Upside Potential?

Bicycle Therapeutics First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Simply Wall St.

4 months ago

Bicycle Therapeutics First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags

Bicycle Therapeutics price target lowered to $15 from $40 at Barclays

TipRanks

4 months ago

Bicycle Therapeutics price target lowered to $15 from $40 at Barclays

MT Newswires

4 months ago

RBC Cuts Price Target on Bicycle Therapeutics to $32 From $35, Keeps Outperform, Speculative Risk

Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results

Business Wire

4 months ago

Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results

Bicycle Therapeutics Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for MT1-MMP at the American Association for Cancer Research Annual Meeting 2025

Business Wire

4 months ago

Bicycle Therapeutics Announces Presentation of Additional Human Radiopharmaceutical Imaging Data for MT1-MMP at the American Association for Cancer Research Annual Meeting 2025

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

5 months ago

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Bicycle Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

Business Wire

5 months ago

Bicycle Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

MT Newswires

5 months ago

Bicycle Therapeutics Names Felix J. Baker as Chairman

Bicycle Therapeutics Announces New Board and Key Clinical Leadership Appointments

Business Wire

5 months ago

Bicycle Therapeutics Announces New Board and Key Clinical Leadership Appointments

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

6 months ago

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Bicycle Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

6 months ago

Bicycle Therapeutics Full Year 2024 Earnings: EPS Beats Expectations, Revenues Lag

Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results

Business Wire

6 months ago

Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results

Bicycle Therapeutics (BCYC): Among The Small–Cap Stocks Insiders Are Selling Recently

Insider Monkey

6 months ago

Bicycle Therapeutics (BCYC): Among The Small–Cap Stocks Insiders Are Selling Recently

Bicycle Therapeutics (NASDAQ:BCYC) shareholders have endured a 74% loss from investing in the stock three years ago

Simply Wall St.

7 months ago

Bicycle Therapeutics (NASDAQ:BCYC) shareholders have endured a 74% loss from investing in the stock three years ago

Bicycle Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Business Wire

7 months ago

Bicycle Therapeutics to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

7 months ago

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Bicycle Therapeutics Announces Updated Topline Zelenectide Pevedotin Data and Highlights 2025 Strategic Priorities and Milestones

Business Wire

7 months ago

Bicycle Therapeutics Announces Updated Topline Zelenectide Pevedotin Data and Highlights 2025 Strategic Priorities and Milestones

Bicycle Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Business Wire

7 months ago

Bicycle Therapeutics to Present at 43rd Annual J.P. Morgan Healthcare Conference

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

8 months ago

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

First Solar, Frontier Communications, and More Stocks See Action From Activist Investors

Barrons.com

8 months ago

First Solar, Frontier Communications, and More Stocks See Action From Activist Investors

MT Newswires

8 months ago

B. Riley Adjusts Price Target on Bicycle Therapeutics to $17 From $28, Keeps Neutral Rating

MT Newswires

8 months ago

Bicycle Therapeutics Reports Updates Across Zelenectide Pevedotin Program; Shares Slump

Bicycle Therapeutics Lead Cancer Drug Combined With Merck's Blockbuster Drug Shows 60% Overall Response Rate In Urothelial Cancer Patients

Benzinga

8 months ago

Bicycle Therapeutics Lead Cancer Drug Combined With Merck's Blockbuster Drug Shows 60% Overall Response Rate In Urothelial Cancer Patients

We're Hopeful That Bicycle Therapeutics (NASDAQ:BCYC) Will Use Its Cash Wisely

Simply Wall St.

8 months ago

We're Hopeful That Bicycle Therapeutics (NASDAQ:BCYC) Will Use Its Cash Wisely

Bicycle Therapeutics Announces Data Updates Across Zelenectide Pevedotin Program and Development Strategy Leveraging NECTIN4 Gene Amplification

Business Wire

8 months ago

Bicycle Therapeutics Announces Data Updates Across Zelenectide Pevedotin Program and Development Strategy Leveraging NECTIN4 Gene Amplification

Bicycle Therapeutics Expands Clinical Advisory Board with Three Distinguished Global Oncology Experts

Business Wire

8 months ago

Bicycle Therapeutics Expands Clinical Advisory Board with Three Distinguished Global Oncology Experts

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

9 months ago

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Bicycle Therapeutics to Present Data for Zelenectide Pevedotin at 2024 San Antonio Breast Cancer Symposium and Provide Program Update

Business Wire

9 months ago

Bicycle Therapeutics to Present Data for Zelenectide Pevedotin at 2024 San Antonio Breast Cancer Symposium and Provide Program Update

Is Bicycle Therapeutics plc (BCYC) Top Performing European Stock Heading into 2025?

Insider Monkey

9 months ago

Is Bicycle Therapeutics plc (BCYC) Top Performing European Stock Heading into 2025?

Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference

Business Wire

9 months ago

Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference

MT Newswires

9 months ago

Stephens Starts Bicycle Therapeutics With Equalweight Rating

Bicycle Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

10 months ago

Bicycle Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

10 months ago

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results

Business Wire

10 months ago

Bicycle Therapeutics Reports Recent Business Progress and Third Quarter 2024 Financial Results

Bicycle Therapeutics Announces First Human Imaging Data from European Association of Nuclear Medicine 2024 Congress and Outlines Strategy for Leadership in Next-Generation Radiopharmaceuticals

Business Wire

10 months ago

Bicycle Therapeutics Announces First Human Imaging Data from European Association of Nuclear Medicine 2024 Congress and Outlines Strategy for Leadership in Next-Generation Radiopharmaceuticals

Bicycle Therapeutics (BCYC): High-Growth UK Stock with Innovative Peptide Technology

Insider Monkey

10 months ago

Bicycle Therapeutics (BCYC): High-Growth UK Stock with Innovative Peptide Technology

Bicycle Therapeutics to Present Radiopharmaceuticals Data at European Association of Nuclear Medicine 2024 Congress

Business Wire

10 months ago

Bicycle Therapeutics to Present Radiopharmaceuticals Data at European Association of Nuclear Medicine 2024 Congress

Bicycle Therapeutics (BCYC) Soars 5.7%: Is Further Upside Left in the Stock?

Zacks

10 months ago

Bicycle Therapeutics (BCYC) Soars 5.7%: Is Further Upside Left in the Stock?

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

a year ago

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Bicycle Therapeutics Presents Updated Clinical Results Across Oncology Pipeline at ESMO Congress 2024

Business Wire

a year ago

Bicycle Therapeutics Presents Updated Clinical Results Across Oncology Pipeline at ESMO Congress 2024

Bicycle Therapeutics' Lead Cancer Candidate's Has High-Opportunity, Analyst Initiates With Bullish Tone

Benzinga

a year ago

Bicycle Therapeutics' Lead Cancer Candidate's Has High-Opportunity, Analyst Initiates With Bullish Tone

MT Newswires

a year ago

RBC Initiates Bicycle Therapeutics at Outperform, Speculative Risk With $35 Price Target

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

a year ago

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Bicycle Therapeutics (NASDAQ:BCYC) shareholders have earned a 26% CAGR over the last five years

Simply Wall St.

a year ago

Bicycle Therapeutics (NASDAQ:BCYC) shareholders have earned a 26% CAGR over the last five years

Bicycle Therapeutics to Participate in Upcoming Investor Conferences

Business Wire

a year ago

Bicycle Therapeutics to Participate in Upcoming Investor Conferences

What Makes Bicycle Therapeutics (BCYC) a New Buy Stock

Zacks

a year ago

What Makes Bicycle Therapeutics (BCYC) a New Buy Stock

Wall Street Analysts See an 88.94% Upside in Bicycle Therapeutics (BCYC): Can the Stock Really Move This High?

Zacks

a year ago

Wall Street Analysts See an 88.94% Upside in Bicycle Therapeutics (BCYC): Can the Stock Really Move This High?

MT Newswires

a year ago

B. Riley Downgrades Bicycle Therapeutics to Neutral From Buy, Cuts Price Target to $28 From $33

MT Newswires

a year ago

Bicycle Therapeutics Q2 Net Loss Narrows, Revenue Lower

Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results

Business Wire

a year ago

Bicycle Therapeutics Reports Recent Business Progress and Second Quarter 2024 Financial Results

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Business Wire

a year ago

Bicycle Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Bicycle Therapeutics Announces Four Abstracts Accepted for Presentation at the ESMO Congress 2024

Business Wire

a year ago

Bicycle Therapeutics Announces Four Abstracts Accepted for Presentation at the ESMO Congress 2024

Are Medical Stocks Lagging Bicycle Therapeutics (BCYC) This Year?

Zacks

a year ago

Are Medical Stocks Lagging Bicycle Therapeutics (BCYC) This Year?

Top 5 Small-Cap Biotechnology Stocks for a Stable Portfolio

Zacks

a year ago

Top 5 Small-Cap Biotechnology Stocks for a Stable Portfolio

Is Bicycle Therapeutics (BCYC) Stock Outpacing Its Medical Peers This Year?

Zacks

a year ago

Is Bicycle Therapeutics (BCYC) Stock Outpacing Its Medical Peers This Year?

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

CNW Group

a year ago

Hyundai Motor Presents Its First Film 'Night Fishing' in Collaboration with K-Movie Star Son Sukku

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

PR Newswire

a year ago

IMAGO AIOS Prime Clinches Red Dot Award for 2024, Expands US Footprint with New Boston Warehouse

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

Business Wire

a year ago

Seibu Ikebukuro Main Store Slated for Summer 2025 Grand Re-opening as a New Department Store

New Zealand scraps plan to tax livestock burps, farts

AFP

a year ago

New Zealand scraps plan to tax livestock burps, farts

Business Wire

a year ago

InnoCare Announces Clearance of Clinical Trial of TYK2 Inhibitor ICP-332 by U.S. FDA

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

The Wall Street Journal

a year ago

ECB’s Lagarde Sees Multi-Meeting Rate Holds A Possibility

UK Unemployment Rises in Sign Inflationary Pressures Cool

Bloomberg

a year ago

UK Unemployment Rises in Sign Inflationary Pressures Cool

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Simply Wall St.

a year ago

Insider-Owned Growth Companies On The Chinese Exchange In June 2024

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Business Wire

a year ago

Engelhart Commodities Trading Partners Agrees to Acquire Trailstone, Strengthening Commitment to the Energy Transition

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

GlobeNewswire

a year ago

Delfi Meedia, a subsidiary of AS Ekspress Grupp to acquire business operations of Eesti Koolitus- ja Konverentsikeskus

Share buy-back programme - week 23

GlobeNewswire

a year ago

Share buy-back programme - week 23

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Simply Wall St.

a year ago

Do Scientex Berhad's (KLSE:SCIENTX) Earnings Warrant Your Attention?

Japan's service sector mood hits nearly 2-year low in May

Reuters

a year ago

Japan's service sector mood hits nearly 2-year low in May

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

AFP

a year ago

N. Korea sends more balloons as Kim's sister warns of 'new counteraction'

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

GlobeNewswire

a year ago

Velcan Holdings: buyback offer of 500 000 shares at Eur 14.5 per share

Enduring role of 'treasuring the past' hailed

PR Newswire

a year ago

Enduring role of 'treasuring the past' hailed

Business Wire

a year ago

Bicycle Therapeutics to Participate in Upcoming Investor Conferences

Bicycle Therapeutics (BCYC) Up as PIPE Funding Set to Make $555M

Zacks

a year ago

Bicycle Therapeutics (BCYC) Up as PIPE Funding Set to Make $555M

Wall Street Analysts Think Bicycle Therapeutics (BCYC) Could Surge 85.52%: Read This Before Placing a Bet

Zacks

a year ago

Wall Street Analysts Think Bicycle Therapeutics (BCYC) Could Surge 85.52%: Read This Before Placing a Bet

Business Wire

a year ago

Bicycle Therapeutics to Present Pharmacokinetic and Safety Evaluation of Lead BTC® Molecules in Phase 1/2 Trials at the 2024 ASCO Annual Meeting

MT Newswires

a year ago

Bicycle Therapeutics Expects to Raise $555 Million From Private Investment in Public Equity Financing

Business Wire

a year ago

Bicycle Therapeutics Announces $555 Million Private Placement Equity Financing

Is Bicycle Therapeutics (BCYC) Outperforming Other Medical Stocks This Year?

Zacks

a year ago

Is Bicycle Therapeutics (BCYC) Outperforming Other Medical Stocks This Year?

Upgrade: Analysts Just Made A Massive Increase To Their Bicycle Therapeutics plc (NASDAQ:BCYC) Forecasts

Simply Wall St.

a year ago

Upgrade: Analysts Just Made A Massive Increase To Their Bicycle Therapeutics plc (NASDAQ:BCYC) Forecasts

Bicycle Therapeutics (BCYC) Moves to Buy: Rationale Behind the Upgrade

Zacks

a year ago

Bicycle Therapeutics (BCYC) Moves to Buy: Rationale Behind the Upgrade

Wall Street Analysts See a 77.22% Upside in Bicycle Therapeutics (BCYC): Can the Stock Really Move This High?

Zacks

a year ago

Wall Street Analysts See a 77.22% Upside in Bicycle Therapeutics (BCYC): Can the Stock Really Move This High?

Bicycle Therapeutics First Quarter 2024 Earnings: Beats Expectations

Simply Wall St.

a year ago

Bicycle Therapeutics First Quarter 2024 Earnings: Beats Expectations

GuruFocus.com

a year ago

Bicycle Therapeutics PLC (BCYC) Q1 2024 Earnings: Narrowing Losses Amidst Robust R&D Progress

Business Wire

a year ago

Bicycle Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results

Business Wire

a year ago

Bicycle Therapeutics Announces Two Abstracts Accepted for Presentation at the 2024 ASCO Annual Meeting

Business Wire

a year ago

Bicycle Therapeutics to Participate in the 23rd Annual Needham Virtual Healthcare Conference

Business Wire

a year ago

Bicycle Therapeutics to Present at the AACR Annual Meeting 2024

Business Wire

a year ago

Bicycle Therapeutics to Participate in Upcoming Investor Conferences

Earnings Update: Bicycle Therapeutics plc (NASDAQ:BCYC) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

Simply Wall St.

2 years ago

Earnings Update: Bicycle Therapeutics plc (NASDAQ:BCYC) Just Reported Its Yearly Results And Analysts Are Updating Their Forecasts

Bicycle Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Simply Wall St.

2 years ago

Bicycle Therapeutics Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag

Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results

Business Wire

2 years ago

Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2023 Financial Results

Business Wire

2 years ago

Bicycle Therapeutics to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference

Share on Social Networks: